Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Medicare program expenditures associated with hospice use.

Campbell DE, Lynn J, Louis TA, Shugarman LR.

Ann Intern Med. 2004 Feb 17;140(4):269-77.

PMID:
14970150
2.

Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.

Iezzoni LI, Ngo LH, Li D, Roetzheim RG, Drews RE, McCarthy EP.

Arch Phys Med Rehabil. 2008 Apr;89(4):595-601. doi: 10.1016/j.apmr.2007.09.042. Review.

PMID:
18373987
3.

Government and private insurance medical programs as well as MDVIP, an update.

Edlich RF, Winters KL, Brit LD, Long WB.

J Long Term Eff Med Implants. 2004;14(3):243-50. Review.

PMID:
15301667
4.

The health status and utilization patterns of the elderly: implications for setting Medicare payments to HMOs.

Gruenberg L, Tompkins C, Porell F.

Adv Health Econ Health Serv Res. 1989;10:41-73. Review.

PMID:
10304291
5.

The economics of dying. The illusion of cost savings at the end of life.

Emanuel EJ, Emanuel LL.

N Engl J Med. 1994 Feb 24;330(8):540-4. Review. No abstract available.

6.

A review of barriers to utilization of the medicare hospice benefits in urban populations and strategies for enhanced access.

O'Mahony S, McHenry J, Snow D, Cassin C, Schumacher D, Selwyn PA.

J Urban Health. 2008 Mar;85(2):281-90. doi: 10.1007/s11524-008-9258-y. Review.

7.

Economics of hospice care.

Carney K, Burns N.

Oncol Nurs Forum. 1991 May-Jun;18(4):761-8. Review.

PMID:
1906167
8.

The role of hospice care in the nursing home setting.

Miller SC, Mor VN.

J Palliat Med. 2002 Apr;5(2):271-7. Review.

9.

Can health promotion programs save Medicare money?

Goetzel RZ, Shechter D, Ozminkowski RJ, Stapleton DC, Lapin PJ, McGinnis JM, Gordon CR, Breslow L.

Clin Interv Aging. 2007;2(1):117-22. Review.

10.

The intersection of the Medicare end-stage renal disease (ESRD) benefit and hospice: an overview for home care and hospice clinicians.

Castner D, Bednarski D.

Home Healthc Nurse. 2011 Sep;29(8):464-76. doi: 10.1097/NHH.0b013e31821fea6f. Review.

PMID:
21881427
11.

Hospice: what to do when anti-cancer therapy is no longer appropriate, effective, or desired.

Kinzbrunner BM.

Semin Oncol. 1994 Dec;21(6):792-8. Review. No abstract available.

PMID:
7527597
13.

Race, Any Cancer, Income, or Cognitive Function: What Inf luences Hospice or Aggressive Services Use at the End of Life Among Community-Dwelling Medicare Beneficiaries?

Karikari-Martin P, McCann JJ, Farran CJ, Hebert LE, Haffer SC, Phillips M.

Am J Hosp Palliat Care. 2016 Jul;33(6):537-45. doi: 10.1177/1049909115574263. Epub 2015 Mar 9. Review. No abstract available.

PMID:
25753184
14.

Review of Medicare's proposed hospice eligibility criteria for select noncancer patients.

Schonwetter RS, Soendker S, Perron V, Martin B, Robinson BE, Thal AE.

Am J Hosp Palliat Care. 1998 May-Jun;15(3):155-8. Review.

PMID:
9729961
15.

Bundling Payments for Episodes of Surgical Care.

Tsai TC, Miller DC.

JAMA Surg. 2015 Sep;150(9):905-6. doi: 10.1001/jamasurg.2015.1236. Review. No abstract available.

PMID:
26154825

Supplemental Content

Support Center